New seizure drug tested in kids: could it be a better option?
NCT ID NCT07163572
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study compared two intravenous seizure medications, brivaracetam and levetiracetam, in 152 children aged 1 month to 16 years with status epilepticus (a prolonged seizure emergency). The goal was to see which drug stopped seizures faster within 30 minutes. Researchers also tracked side effects. The results may help doctors choose the best treatment for children in this critical situation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
brivaracetam and levetiracetam (intravenous seizure medications)
What this could lead to
If brivaracetam works as well or better than levetiracetam, it could give doctors another option to quickly stop prolonged seizures in children.
What could go wrong
This is a single-center study with 152 children, so results may not apply to all kids. The trial only looked at stopping seizures within 30 minutes, not long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STATUS EPILEPTICUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Children's Hospital and Institute of Child Health
Multan, Punjab Province, 66000, Pakistan